Literature DB >> 12439746

Rabies virus P and small P products interact directly with PML and reorganize PML nuclear bodies.

Danielle Blondel1, Tarick Regad, Nicolas Poisson, Benjamen Pavie, Francis Harper, Pier Paolo Pandolfi, Hugues De Thé, Mounira K Chelbi-Alix.   

Abstract

The interferon-induced promyelocytic leukaemia (PML) protein localizes both in the nucleoplasm and in matrix-associated multi-protein complexes known as nuclear bodies (NBs). NBs are disorganized in acute promyelocytic leukaemia or during some viral infections, suggesting that PML NBs could be a part of cellular defense mechanism. Rabies virus, a member of the rhabdoviridae family, replicates in the cytoplasm. Rabies phosphoprotein P and four other amino-terminally truncated products (P2, P3, P4, P5) are all translated from P mRNA. P and P2 are located in the cytoplasm, whereas P3, P4 and P5 are found mostly in the nucleus. Infection with rabies virus reorganized PML NBs. PML NBs became larger and appeared as dense aggregates when analysed by confocal or electron microscopy, respectively. The expression of P sequesters PML in the cytoplasm where both proteins colocalize, whereas that of P3 results in an increase in PML body size, as observed in infected cells. The P and P3 interacted directly in vivo and in vitro with PML. The C-terminal domain of P and the PML RING finger seem to be involved in this binding. Moreover, PML-/- primary mouse embryonic fibroblasts expressed viral proteins at a higher level and produced 20 times more virus than wild-type cells, suggesting that the absence of all PML isoforms resulted in an increase in rabies virus replication.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12439746     DOI: 10.1038/sj.onc.1205931

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  64 in total

1.  Resistance to rabies virus infection conferred by the PMLIV isoform.

Authors:  Danielle Blondel; Sabrina Kheddache; Xavier Lahaye; Laurent Dianoux; Mounira K Chelbi-Alix
Journal:  J Virol       Date:  2010-08-11       Impact factor: 5.103

2.  Involvement of the rabies virus phosphoprotein gene in neuroinvasiveness.

Authors:  Satoko Yamaoka; Naoto Ito; Seii Ohka; Shohei Kaneda; Hiroko Nakamura; Takahiro Agari; Tatsunori Masatani; Keisuke Nakagawa; Kazuma Okada; Kota Okadera; Hiromichi Mitake; Teruo Fujii; Makoto Sugiyama
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

3.  Rabies virus P protein interacts with STAT1 and inhibits interferon signal transduction pathways.

Authors:  Aurore Vidy; Mounira Chelbi-Alix; Danielle Blondel
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

4.  Critical Role of K1685 and K1829 in the Large Protein of Rabies Virus in Viral Pathogenicity and Immune Evasion.

Authors:  Dayong Tian; Zhaochen Luo; Ming Zhou; Mingming Li; Lan Yu; Chong Wang; Jiaolong Yuan; Fang Li; Bin Tian; Baokun Sui; Huanchun Chen; Zhen F Fu; Ling Zhao
Journal:  J Virol       Date:  2015-10-14       Impact factor: 5.103

5.  The LC8-RavP ensemble Structure Evinces A Role for LC8 in Regulating Lyssavirus Polymerase Functionality.

Authors:  Nathan E Jespersen; Cedric Leyrat; Francine C Gérard; Jean-Marie Bourhis; Danielle Blondel; Marc Jamin; Elisar Barbar
Journal:  J Mol Biol       Date:  2019-10-18       Impact factor: 5.469

6.  Quantitative proteomic analysis of A549 cells infected with human respiratory syncytial virus.

Authors:  Diane C Munday; Edward Emmott; Rebecca Surtees; Charles-Hugues Lardeau; Weining Wu; W Paul Duprex; Brian K Dove; John N Barr; Julian A Hiscox
Journal:  Mol Cell Proteomics       Date:  2010-07-20       Impact factor: 5.911

Review 7.  The cell biology of rabies virus: using stealth to reach the brain.

Authors:  Matthias J Schnell; James P McGettigan; Christoph Wirblich; Amy Papaneri
Journal:  Nat Rev Microbiol       Date:  2010-01       Impact factor: 60.633

8.  The nucleocytoplasmic rabies virus P protein counteracts interferon signaling by inhibiting both nuclear accumulation and DNA binding of STAT1.

Authors:  Aurore Vidy; Jamila El Bougrini; Mounira K Chelbi-Alix; Danielle Blondel
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

9.  Peptides that mimic the amino-terminal end of the rabies virus phosphoprotein have antiviral activity.

Authors:  Guillaume Castel; Mohamed Chtéoui; Grégory Caignard; Christophe Préhaud; Stéphanie Méhouas; Eléonore Réal; Corinne Jallet; Yves Jacob; Rob W H Ruigrok; Noël Tordo
Journal:  J Virol       Date:  2009-08-12       Impact factor: 5.103

10.  Concepts in the pathogenesis of rabies.

Authors:  Bernhard Dietzschold; Jianwei Li; Milosz Faber; Matthias Schnell
Journal:  Future Virol       Date:  2008-09       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.